This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Cell Phones Help Track Flu on Campus
    New methods for analyzing personal health and lifestyle data captured through wearable devices or smartphone apps can help identify college students at risk of catching the flu, say researchers at Duke University and the University of North Carolina-Chapel Hill. With help ...More
    August 18, 2015 Posted in News
  • Flu Could Be Prevented Without a Vaccine Someday, Scientists Suggest
    Researchers have discovered a way to trigger a preventive response to a flu infection without any help from the usual players – the virus itself or interferon, a powerful infection fighter. The finding, in both mouse and human cells, suggests that manipulating a ...More
    August 12, 2015 Posted in News
  • Researchers Develop a Better Flu Vaccine
    Johns Hopkins Bloomberg School of Public Health researchers say they have developed a method that could make a nasal spray flu vaccine effective for those under 2 and over 49 – two groups for which the vaccine is not approved. By studying the weakened flu virus ...More
    August 10, 2015 Posted in News
  • Computer Model Forecasts Flu Outbreaks in a Subtropical Climate
    Scientists at Columbia University's Mailman School of Public Health and the School of Public Health of Li Ka Shing Faculty of Medicine at the University of Hong Kong have shown for the first time that it is possible to predict the timing and intensity of influenza outbreaks ...More
    July 31, 2015 Posted in News
  • Adjuvants Improve Immune Response to H7N9 Flu Vaccine
    In a phase 2 trial that included nearly 1,000 adults, the AS03 and MF59 adjuvants (a component that improves immune response of inactivated influenza vaccines) increased the immune responses to two doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted ...More
    July 21, 2015 Posted in News
  • NIAID Research Could Aid Development of a Universal Flu Vaccine
    A vaccine that protects against a wide variety of influenza viruses (a so-called universal flu vaccine) is a critical public health goal given the significant rates of illness and death caused by seasonal influenza and the potentially devastating effects of a pandemic ...More
    July 21, 2015 Posted in News
  • GSK Begins Shipping 2015-16 U.S. Flu Vaccines
    GSK announces that it has begun shipping FLUARIX® QUADRIVALENT (Influenza Vaccine) doses to U.S. healthcare providers, following licensing and lot-release approval from the Food and Drug Administration (FDA)'s Center for Biologics Evaluation and Research. “To help ...More
    July 16, 2015 Posted in News
  • Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses in U.S.
    Sanofi Pasteur, the vaccines division of Sanofi, announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2015-2016 influenza season have been released by the Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 ...More
    July 14, 2015 Posted in News
  • Discovery Points to a New Path Toward a Universal Flu Vaccine
    Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues ...More
    July 2, 2015 Posted in News
  • Scientists Identify 'Decoy' Molecule That Could Help Reduce Risk of Flu Death
    The flu virus can be lethal, but what is often just as dangerous is the body's own reaction to the invader. This immune response consists of an inflammatory attack, meant to kill the virus. But if it gets too aggressive, this counterattack can end up harming the body's own ...More
    June 26, 2015 Posted in News